157 related articles for article (PubMed ID: 18356460)
1. False-positive findings on 18F-FDG PET/CT: differentiation of hibernoma and malignant fatty tumor on the basis of fluctuating standardized uptake values.
Smith CS; Teruya-Feldstein J; Caravelli JF; Yeung HW
AJR Am J Roentgenol; 2008 Apr; 190(4):1091-6. PubMed ID: 18356460
[TBL] [Abstract][Full Text] [Related]
2. Mediastinal hibernoma simulates a malignant lesion on dual time point FDG imaging.
Burdick MJ; Jolles PR; Grimes MM; Henry DA
Lung Cancer; 2008 Mar; 59(3):391-4. PubMed ID: 17905469
[TBL] [Abstract][Full Text] [Related]
3. Uptake in supraclavicular area fat ("USA-Fat"): description on 18F-FDG PET/CT.
Cohade C; Osman M; Pannu HK; Wahl RL
J Nucl Med; 2003 Feb; 44(2):170-6. PubMed ID: 12571205
[TBL] [Abstract][Full Text] [Related]
4. PET evaluation of fatty tumors in the extremity: possibility of using the standardized uptake value (SUV) to differentiate benign tumors from liposarcoma.
Suzuki R; Watanabe H; Yanagawa T; Sato J; Shinozaki T; Suzuki H; Endo K; Takagishi K
Ann Nucl Med; 2005 Dec; 19(8):661-70. PubMed ID: 16444991
[TBL] [Abstract][Full Text] [Related]
5. Intraosseous Hibernoma: Five Cases and a Review of the Literature.
Myslicki FA; Rosenberg AE; Chaitowitz I; Subhawong TK
J Comput Assist Tomogr; 2019; 43(5):793-798. PubMed ID: 31453977
[TBL] [Abstract][Full Text] [Related]
6. Focal parenchymal lung lesions showing a potential of false-positive and false-negative interpretations on integrated PET/CT.
Shim SS; Lee KS; Kim BT; Choi JY; Chung MJ; Lee EJ
AJR Am J Roentgenol; 2006 Mar; 186(3):639-48. PubMed ID: 16498090
[TBL] [Abstract][Full Text] [Related]
7. Overexpression of hexokinase-2 in giant cell tumor of bone is associated with false positive in bone tumor on FDG-PET/CT.
Hoshi M; Takada J; Oebisu N; Hata K; Ieguchi M; Nakamura H
Arch Orthop Trauma Surg; 2012 Nov; 132(11):1561-8. PubMed ID: 22825642
[TBL] [Abstract][Full Text] [Related]
8. Clinical findings of hibernoma of the buttock and thigh: rare involvements and extremely high uptake of FDG-PET.
Nishida J; Ehara S; Shiraishi H; Tada H; Satoh T; Okada K; Shimamura T
Med Sci Monit; 2009 Jul; 15(7):CS117-22. PubMed ID: 19564831
[TBL] [Abstract][Full Text] [Related]
9. Focal FDG uptake in mediastinal brown fat mimicking malignancy: a potential pitfall resolved on PET/CT.
Truong MT; Erasmus JJ; Munden RF; Marom EM; Sabloff BS; Gladish GW; Podoloff DA; Macapinlac HA
AJR Am J Roentgenol; 2004 Oct; 183(4):1127-32. PubMed ID: 15385319
[TBL] [Abstract][Full Text] [Related]
10. Hibernoma: 18F FDG PET/CT imaging.
Subramaniam RM; Clayton AC; Karantanis D; Collins DA
J Thorac Oncol; 2007 Jun; 2(6):569-70. PubMed ID: 17545854
[TBL] [Abstract][Full Text] [Related]
11. Propranolol 18F-FDG PET/CT: A Noninvasive Approach for Differential Diagnosis of Hibernoma and Liposarcoma.
Ciappuccini R; Bardet S; Aide N
Clin Nucl Med; 2017 Nov; 42(11):879-880. PubMed ID: 28902737
[TBL] [Abstract][Full Text] [Related]
12. [Value of dual-time-point (18)F-fluorodeoxyglucose integrated positron emission and computed tomography in differentiation of malignant from benign gastrointestinal diseases].
Xu XX; Cheng J; Xu WG; Dai D; Song XY; Ma WC; Zhu L; Zhu X
Zhonghua Zhong Liu Za Zhi; 2012 May; 34(5):364-8. PubMed ID: 22883458
[TBL] [Abstract][Full Text] [Related]
13. 18F-FDG PET in characterizing adrenal lesions detected on CT or MRI.
Yun M; Kim W; Alnafisi N; Lacorte L; Jang S; Alavi A
J Nucl Med; 2001 Dec; 42(12):1795-9. PubMed ID: 11752075
[TBL] [Abstract][Full Text] [Related]
14. Hibernoma as an incidental finding in the 18F-FDG PET/CT of a patient with melanoma.
Marcoval J; Sabaté-Llobera A; Bermejo J; Fornons-Servent R
Melanoma Res; 2020 Aug; 30(4):420-422. PubMed ID: 30358644
[TBL] [Abstract][Full Text] [Related]
15. The maximum standardized uptake values on integrated FDG-PET/CT is useful in differentiating benign from malignant pulmonary nodules.
Bryant AS; Cerfolio RJ
Ann Thorac Surg; 2006 Sep; 82(3):1016-20. PubMed ID: 16928527
[TBL] [Abstract][Full Text] [Related]
16. A Rare Case of Hibernoma Occasionally Identified by 18F-fluorodeoxyglucose Positron Emission Tomography/Computed Tomography in a Patient with Lung Cancer.
Penna D; Quartuccio N; Testa C; Arena V; Cistaro A; Pelosi E
Cureus; 2017 Mar; 9(3):e1124. PubMed ID: 28465871
[TBL] [Abstract][Full Text] [Related]
17. The value of dual time point (18)F-FDG PET imaging for the differentiation between malignant and benign lesions.
Lan XL; Zhang YX; Wu ZJ; Jia Q; Wei H; Gao ZR
Clin Radiol; 2008 Jul; 63(7):756-64. PubMed ID: 18555033
[TBL] [Abstract][Full Text] [Related]
18. Hibernomas show intense accumulation of FDG positron emission tomography.
Tsuchiya T; Osanai T; Ishikawa A; Kato N; Watanabe Y; Ogino T
J Comput Assist Tomogr; 2006; 30(2):333-6. PubMed ID: 16628059
[TBL] [Abstract][Full Text] [Related]
19. Patterns of (18)F-FDG uptake in adipose tissue and muscle: a potential source of false-positives for PET.
Yeung HW; Grewal RK; Gonen M; Schöder H; Larson SM
J Nucl Med; 2003 Nov; 44(11):1789-96. PubMed ID: 14602861
[TBL] [Abstract][Full Text] [Related]
20. Increased (18)F-fluorodeoxyglucose uptake in benign, nonphysiologic lesions found on whole-body positron emission tomography/computed tomography (PET/CT): accumulated data from four years of experience with PET/CT.
Metser U; Even-Sapir E
Semin Nucl Med; 2007 May; 37(3):206-22. PubMed ID: 17418153
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
